Detalhe da pesquisa
1.
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Nature
; 621(7980): 868-876, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674077
2.
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort.
Cancer Immunol Immunother
; 72(7): 2075-2086, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806983
3.
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients.
J Transl Med
; 20(1): 370, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974414
4.
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer.
BMC Cancer
; 22(1): 407, 2022 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421940
5.
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.
BMC Cancer
; 17(1): 241, 2017 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28376728
6.
Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.
BMC Cancer
; 16: 143, 2016 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908167
7.
Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients.
BMC Clin Pathol
; 15: 21, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26664297
8.
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study.
Clin Lung Cancer
; 24(2): 137-144, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564297
9.
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 53, 2023 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344474
10.
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.
JCO Precis Oncol
; 6: e2000368, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294223
11.
Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.
BMC Cancer
; 16: 275, 2016 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27090641
12.
Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
J Cutan Pathol
; 38(12): 961-6, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22050093
13.
A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies.
Heliyon
; 7(3): e06438, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748492
14.
Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab.
Ther Adv Med Oncol
; 13: 17588359211010156, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953802
15.
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy.
Breast Cancer Res
; 12(4): R47, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20615243
16.
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence.
BMC Cancer
; 10: 108, 2010 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20307320
17.
TLE3 as a candidate biomarker of response to taxane therapy.
Breast Cancer Res
; 11(2): R17, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19309506
18.
A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.
Mod Pathol
; 22(8): 1032-43, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19430419
19.
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials.
Clin Cancer Res
; 14(20): 6602-9, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18927301
20.
Gene expression patterns within cell lines are predictive of chemosensitivity.
BMC Genomics
; 9: 74, 2008 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-18261237